Recent News

• 09.04.2025 - ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners
• 08.12.2025 - ClearPoint Neuro Reports Second Quarter 2025 Results
• 08.04.2025 - ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio
• 07.23.2025 - ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025

Recent Filings

• 09.04.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.12.2025 - 8-K Current report
• 08.12.2025 - EX-99.1 EX-99.1
• 08.04.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.29.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 07.17.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 07.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.02.2025 - 4 Statement of changes in beneficial ownership of securities